No Age-Related Focus

Pirfenidone ameliorates pulmonary arterial pressure and neointimal remodeling in experimental pulmonary arterial hypertension by suppressing NLRP3 inflammasome activation

Emmanouil Mavrogiannis, Quint A. J. Hagdorn, Venetia Bazioti, Johannes M. Douwes, Diederik E. Van Der Feen, Silke U. Oberdorf‐Maass, Marit Westerterp, Rolf M. F. BergerBeatrix Children’s Hospital, University Medical Center Groningen and University of GroningenNetherlands Pulmonary CirculationPulm Circ 2022; 12: DOI: 10.1002/pul2.12101 AbstractPulmonary arterial hypertension (PAH) is a fatal disease characterized by increased pulmonary arterial pressure,

Pirfenidone ameliorates pulmonary arterial pressure and neointimal remodeling in experimental pulmonary arterial hypertension by suppressing NLRP3 inflammasome activation Read More »

Synchrotron-based phase-contrast micro-CT as a tool for understanding pulmonary vascular pathobiology and the 3-D microanatomy of alveolar capillary dysplasia

Christian Norvik, Christian Karl Westöö, Niccolò Peruzzi, Goran Lovric, Oscar van der Have, Rajmund Mokso, Ida Jeremiasen, Hans Brunnström, Csaba Galambos, Martin Bech, Karin Tran-LundmarkLund University. École Polytechnique Fédérale de Lausanne. Swiss Light Source. University of Colorado.Sweden, Switzerland and United States American Journal of Physiology Lung cellular and Molecular PhysiologyAm J Physiol Lung Cell Mol

Synchrotron-based phase-contrast micro-CT as a tool for understanding pulmonary vascular pathobiology and the 3-D microanatomy of alveolar capillary dysplasia Read More »

Scroll to Top